Carboxymethyl chitosan based redox-responsive micelle for near-infrared fluorescence image-guided photo-chemotherapy of liver cancer. (1st February 2021)

• Record Type: Journal Article
• Authors: Yan, Tingsheng; Hui, Wenxue; Zhu, Siyuan; He, Jinmei; Liu, Zhonghua; Cheng, Jinju
• Is Part Of: Carbohydrate polymers. Volume 253(2021)
• Publication Date: 2021-02-01
• Subjects: Micelle -- Redox-responsive -- Photo-chemotherapy -- Doxorubicin -- Photosensitizer; Polysaccharides -- Periodicals; Polysaccharides -- Periodicals; Polysaccharides -- Périodiques; Electronic journals; 547.78
• DOI: 10.1016/j.carbpol.2020.117284
• Languages: English
• ISSNs: 0144-8617

Abstract

Highlights: A carboxymethyl chitosan based redox-responsive micelle was prepared. The micelles can be used for the co-delivery of doxorubicin and pheophorbide A. The micelles exhibited enhanced NIR imaging of tumour in living mice. This nanoplatform could fully exert the synergistic effect of therapeutic agents. This would become a promising candidate for image-guided therapy of liver cancer. Abstract: High-efficient vectors for the co-delivery of photosensitizers and chemotherapeutics were urgently needed for the combination therapy. In this work, a redox-responsive micelle (PCL-SS-CMC-GA) was prepared for the co-delivery of doxorubicin (DOX) and pheophorbide A (PHA). Poly-ε-caprolactone was linked to carboxymethyl chitosan through a disulfide bond, which was easily broken in the reductive solution to release the payloads. The charge conversion property and glycyrrhetinic acid (GA) targeting ligand of the micelles effectively extended the average residence time (up to 18 times) in circulation and improved their intracellular uptake by HepG2 cells. The micelles exhibited an enhanced tumor accumulation and near infrared (NIR) imaging performance. More interestingly, this nanoplatform could fully exert the synergistic effect of DOX and PHA to improve the inhibition efficiency (with an inhibitory rate of 80.5 %) in vivo . With impressive photo-chemo theranostic and NIR imaging capability, PCL-SS-CMC-GA@DOX/PHA showed great potential in image-guided treatment of liver cancer.